Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients
Authors
Keywords
-
Journal
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 30, Issue 12, Pages 2399-2411
Publisher
American Society of Nephrology (ASN)
Online
2019-10-29
DOI
10.1681/asn.2019030304
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use
- (2019) Jean Kwun et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- OPTN/SRTR 2016 Annual Data Report: Kidney
- (2018) A. Hart et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
- (2018) M. Haas et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Control of Humoral Response in Renal Transplantation by Belatacept Depends on a Direct Effect on B Cells and Impaired T Follicular Helper-B Cell Crosstalk
- (2018) Claire Leibler et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology
- (2018) Candice Roufosse et al. TRANSPLANTATION
- Dual targeting: Combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients
- (2018) Christopher K. Burghuber et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Humoral Compensation after Bortezomib Treatment of Allosensitized Recipients
- (2017) Jean Kwun et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection
- (2017) Farsad Eskandary et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients
- (2017) Michela Cioni et al. Journal of Immunology Research
- Antibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology
- (2016) C. K. Burghuber et al. AMERICAN JOURNAL OF TRANSPLANTATION
- CD28 Costimulation: From Mechanism to Therapy
- (2016) Jonathan H. Esensten et al. IMMUNITY
- Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
- (2016) Meletios A Dimopoulos et al. LANCET ONCOLOGY
- Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation
- (2016) Jong Cheol Jeong et al. MEDICINE
- Immunological characterization of de novo and recall alloantibody suppression by CTLA4Ig in a mouse model of allosensitization
- (2016) Irene Kim et al. TRANSPLANT IMMUNOLOGY
- Neutralizing BAFF/APRIL With Atacicept Prevents Early DSA Formation and AMR Development in T Cell Depletion Induced Nonhuman Primate AMR Model
- (2015) J. Kwun et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
- (2015) Tobias Alexander et al. ANNALS OF THE RHEUMATIC DISEASES
- Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
- (2014) M. Haas et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Prospective Iterative Trial of Proteasome Inhibitor-Based Desensitization
- (2014) E. S. Woodle et al. AMERICAN JOURNAL OF TRANSPLANTATION
- HLA desensitization with bortezomib in a highly sensitized pediatric patient
- (2014) Lindsay J. May et al. PEDIATRIC TRANSPLANTATION
- Kidney Intragraft Donor-Specific Antibodies as Determinant of Antibody-Mediated Lesions and Poor Graft Outcome
- (2013) T. Bachelet et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Costimulation Blockade Alters Germinal Center Responses and Prevents Antibody-Mediated Rejection
- (2013) E. J. Kim et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
- (2013) Alexandre Loupy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Five-Year Outcomes in Living Donor Kidney Transplants With a Positive Crossmatch
- (2012) A. Bentall et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Banff 2011 Meeting Report: New Concepts in Antibody-Mediated Rejection
- (2012) M. Mengel et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?
- (2012) Alejandro M. Gomez et al. Annals of the New York Academy of Sciences
- Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis
- (2011) A. M. Gomez et al. JOURNAL OF IMMUNOLOGY
- Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat
- (2010) R. Vogelbacher et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Protective Immunity Remains Intact After Antibody Removal by Means of Proteasome Inhibition
- (2010) Matthew J. Everly et al. TRANSPLANTATION
- Positive Cross-Match Living Donor Kidney Transplantation: Longer-Term Outcomes
- (2009) A. Haririan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- B7-1/2 (CD80/CD86) Direct Signaling to B Cells Enhances IgG Secretion
- (2009) F. C. Rau et al. JOURNAL OF IMMUNOLOGY
- Proteasome Inhibition Reduces Donor-Specific Antibody Levels
- (2009) M.J. Everly et al. TRANSPLANTATION PROCEEDINGS
- Proteasome Inhibition Causes Apoptosis of Normal Human Plasma Cells Preventing Alloantibody Production
- (2008) D. K. Perry et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
- (2008) Kirsten Neubert et al. NATURE MEDICINE
- Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation
- (2008) Ashley A. Vo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transplant Glomerulopathy: Risk and Prognosis Related to Anti-Human Leukocyte Antigen Class II Antibody Levels
- (2008) Naim Issa et al. TRANSPLANTATION
- Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection
- (2008) Matthew J. Everly et al. TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started